Drug Resistant Models

Comprehensive portfolio of drug resistant models representing clinically relevant mechanisms of resistance:

  • 10+ cancer types
  • 25+ key targets
  • 30+ leading drugs
  • 100+ resistant models
  • Extensive validation data

Our capabilities include cutting-edge bioinformatics and analytical techniques to enable a clear and in-depth understanding of resistance mechanisms

View our AACR poster describing the establishment of a wide panel of drug-induced resistant tumor models

Leverage our extensive panel of CDK4/6 inhibitor resistant breast cancer models

Drug Resistant Models


← Return to Resources
× peptide, amino acid

Contact An Expert Today!